
On July 21, 2026, UK HSE published its agency opinion on the restriction proposal for per- and polyfluoroalkyl substances (PFAS) in firefighting foams.

On July 21, 2026, UK HSE published its agency opinion on the restriction proposal for per- and polyfluoroalkyl substances (PFAS) in firefighting foams.

CIRS Testing provides a complete medical device chemical testing service, built around the chemical-substance requirements of the EU MDR, REACH, RoHS, the POPs Regulation, China NMPA/GB, and US FDA / ISO 10993 frameworks.

On June 30, 2026, the European Commission adopted a draft regulation to include Chlorpyrifos in Part A of Annex I to the POPs Regulation. The official regulation will be published in the EU Official Journal in due course, bringing Chlorpyrifos under formal regulatory control.

On June 19, 2026, Rhode Island Governor Dan McKee signed House Bill H7734. This bill amends the state's Consumer PFAS Ban Act of 2024.

On June 3, 2026, ECHA released a briefing on the SEAC consultation for the PFAS restriction proposal, receiving 3,511 comments within a 60-day period.

On 30 April 2026, the Official Journal of the European Union published Decision (EU) 2026/878. The decision clearly states that the European Union, on behalf of its Member States, will submit a proposal to the Secretariat of the Stockholm Convention on Persistent Organic Pollutants (hereinafter referred to as "the Convention") to recommend the listing of bis(2-ethylhexyl) tetrabromophthalate (abbreviated as TBPH) in Annex A (Elimination) of the Convention.


Per- and Polyfluoroalkyl Substances (PFAS), commonly known as "forever chemicals", feature extremely stable carbon-fluorine bonds, high bioaccumulation potential and suspected endocrine disrupting properties, leading to stringent regulatory restrictions worldwide. According to OECD statistics, the PFAS family comprises over 10,000 substances. Fluoropolymers including Polytetrafluoroethylene (PTFE), FEP, PFA, PVDF and PCTFE are widely applied in cardiovascular catheters, implant coatings, pacemaker wire insulation, as well as sterile high-barrier packaging for medical devices.

On April 20, 2026, the U.S. EPA released the 2026 Interim Guidance on PFAS Destruction and Disposal and opened it for public comment.

Here are five compelling reasons why PCN notification can become your "compliance accelerator."